REYNA PERRY: Open Payments
NPI 1114621307 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,207 in 129 payments from 24 companies in 2025. Trend: 2023 $2,740 · 2024 $3,339 · 2025 $3,207
Food & beverage: $3,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $487 |
| Janssen Pharmaceuticals, Inc | 7 | $346 |
| Teva Pharmaceuticals USA, Inc. | 10 | $336 |
| Neurocrine BioSciences, Inc. | 13 | $280 |
| Otsuka America Pharmaceutical, Inc. | 14 | $259 |
| Lundbeck LLC | 14 | $159 |
| Bioventus LLC | 2 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $144 |
| ARGENX US, INC. | 1 | $125 |
| Stryker Corporation | 1 | $116 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, CAPLYTA, VYVGART, FLOWTRIEVER CATHETER, S.
Industry payments across OH — which companies pay providers there.
